-
1por Arrivé, Elise, Dicko, Fatoumata, Amghar, Hind, Aka, Addi Edmond, Dior, Hélène, Bouah, Belinda, Traoré, Mariam, Ogbo, Patricia, Dago-Akribi, Hortense Aka, Eboua, Tanoh Kassi F., Kouakou, Kouadio, Sy, Haby Signate, Alioum, Ahmadou, Dabis, François, Ekouévi, Didier Koumavi, Leroy, Valériane“…HIV-infected patients were included in this study if they met the following inclusion criteria: aged 10–21 years while on ART; having initiated ART≥200 days before the closure date of the clinic database; followed ≥15 days from ART initiation in clinics with ≥10 adolescents enrolled. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2por Abo, Yao, Zannou Djimon, Marcel, Messou, Eugène, Balestre, Eric, Kouakou, Martial, Akakpo, Jocelyn, Ahouada, Carin, de Rekeneire, Nathalie, Dabis, François, Lewden, Charlotte, Minga, Albert“…BACKGROUND: The causes of severe morbidity in health facilities implementing Antiretroviral Treatment (ART) programmes are poorly documented in sub-Saharan Africa. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3por Derache, Anne, Iwuji, Collins C, Danaviah, Siva, Giandhari, Jennifer, Marcelin, Anne-Geneviève, Calvez, Vincent, de Oliveira, Tulio, Dabis, François, Pillay, Deenan, Gupta, Ravindra K“…METHODS: Within the treatment-as-prevention study in South Africa, we selected participants with available next-generation sequencing (NGS) data for the HIV-1 pol gene at trial entry; they were either ART initiators (n = 1193) or already established on ART (n = 94). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4por Atkinson, Andrew, Miro, Jose M., Mocroft, Amanda, Reiss, Peter, Kirk, Ole, Morlat, Philippe, Ghosn, Jade, Stephan, Christoph, Mussini, Cristina, Antoniadou, Anastasia, Doerholt, Katja, Girardi, Enrico, De Wit, Stéphane, Kraus, David, Zwahlen, Marcel, Furrer, Hansjakob, Antoniadou, A., Castagna, A, Doerholt, K, Fätkenheuer, G, Raben, D, Teira, R, Zangerle, R, Judd, Ali, Zangerle, Robert, Touloumi, Giota, Warszawski, Josiane, Meyer, Laurence, Dabis, François, Krause, Murielle Mary, Leport, Catherine, Wittkop, Linda, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Fätkenheuer, Gerd, Del Amo, Julia, Obel, Niels, Thorne, Claire, Pérez‐Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Noguera‐Julian, Antoni, Antinori, Andrea, d’Arminio Monforte, Antonella, Brockmeyer, Norbert, Prieto, Luis, Conejo, Pablo Rojo, Soriano‐Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Casabona, Jordi, Castagna, Antonella, Goetghebuer, Tessa, Sönnerborg, Anders, Torti, Carlo, Sabin, Caroline, Teira, Ramon, Garrido, Myriam, Haerry, David, Costagliola, Dominique, d’Arminio‐Monforte, Antonella, Castagna, Antonella, del Amo, Julia, Raben, Dorthe, Chêne, Geneviève, Judd, Ali, Conejo, Pablo Rojo, Barger, Diana, Schwimmer, Christine, Termote, Monique, Wittkop, Linda, Frederiksen, Casper M, Raben, Dorthe, Brandt, Rikke Salbøl, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Bucher, Heiner, Cozzi‐Lepri, Alessandro, Dabis, François, d’Arminio Monforte, Antonella, Davies, Mary‐Anne, del Amo, Julia, Dorrucci, Maria, Dunn, David, Egger, Matthias, Guiguet, Marguerite, Grabar, Sophie, Judd, Ali, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Meyer, Laurence, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Phillips, Andrew, Puoti, Massimo, Rohner, Eliane, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, Thorne, Claire, Torti, Carlo, van der Valk, Marc, Wittkop, Linda“…In virologically suppressed patients on ART with CD4 counts of 100 to 200/µL, the incidence of PjP off prophylaxis is below 10/1000 py. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5por Haas, Andreas D, Zaniewski, Elizabeth, Anderegg, Nanina, Ford, Nathan, Fox, Matthew P, Vinikoor, Michael, Dabis, François, Nash, Denis, Sinayobye, Jean d'Amour, Niyongabo, Thêodore, Tanon, Aristophane, Poda, Armel, Adedimeji, Adebola A, Edmonds, Andrew, Davies, Mary‐Ann, Egger, Matthias“…INTRODUCTION: By 2020, 90% of all people diagnosed with HIV should receive long‐term combination antiretroviral therapy (ART). In sub‐Saharan Africa, this target is threatened by loss to follow‐up in ART programmes. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6por Plazy, Melanie, Perriat, Delphine, Gumede, Dumile, Boyer, Sylvie, Pillay, Deenan, Dabis, François, Seeley, Janet, Orne-Gliemann, Joanna“…HCPs also foresaw logistical challenges of universal ART, and were especially concerned about increasing workload and ART shortage. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
7por Boyer, Sylvie, Iwuji, Collins, Gosset, Andréa, Protopopescu, Camelia, Okesola, Nonhlanhla, Plazy, Mélanie, Spire, Bruno, Orne-Gliemann, Joanna, McGrath, Nuala, Pillay, Deenan, Dabis, François, Larmarange, Joseph“…Prompt uptake of antiretroviral treatment (ART) is essential to ensure the success of universal test and treat (UTT) strategies to prevent HIV transmission in high-prevalence settings. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8por Calmy, Alexandra, Balestre, Eric, Bonnet, Fabrice, Boulle, Andrew, Sprinz, Eduardo, Wood, Robin, Delaporte, Eric, Messou, Eugène, McIntyre, James, El Filali, Kamal Marhoum, Schechter, Mauro, Kumarasamy, N, Bangsberg, David, McPhail, Patrick, Van Der Borght, Stefaan, Zala, Carlos, Egger, Matthias, Thiébaut, Rodolphe, Dabis, François“…BACKGROUND: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-level viremia while on antiretroviral treatment (ART) in resource-limited settings. We assessed the impact of on-going HIV-RNA replication on CD4 cell count slopes in patients treated with a first-line combination ART. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9por Kaulich-Bartz, Josee, Dam, Wayne, May, Margaret T., Lederberger, Bruno, Widmer, Urs, Phillips, Andrew N., Grabar, Sophie, Mocroft, Amanda, Vilaro, Josep, van Sighem, Ard, Moreno, Santiago, Dabis, François, Monforte, Antonella D’Arminio, Teira, Ramon, Ingle, Suzanne M., Sterne, Jonathan A.C.“…METHODS: We estimated relative mortality from 6 months after starting antiretroviral therapy (ART), compared with the insured population in each country, among adult patients from European cohorts participating in the ART Cohort Collaboration (ART-CC) who were not infected via injection drug use, had not tested positive for hepatitis C, and started triple ART between 1996–2008. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10“…We included all original research studies published in peer-reviewed journals, which used quantitative indicators of retention in care prior to ART eligibility. PARTICIPANTS: People not yet eligible for ART. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11por Brinkhof, Martin W. G., Boulle, Andrew, Weigel, Ralf, Messou, Eugène, Mathers, Colin, Orrell, Catherine, Dabis, François, Pascoe, Margaret, Egger, Matthias“…BACKGROUND: Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has declined in sub-Saharan Africa, but it is unclear how mortality compares to the non-HIV–infected population. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12por Ekouevi, Didier K, Azondekon, Alain, Dicko, Fatoumata, Malateste, Karen, Touré, Pety, Eboua, François T, Kouadio, Kouakou, Renner, Lorna, Peterson, Kevin, Dabis, François, Sy, Haby Signaté, Leroy, Valeriane“…We describe here the characteristics at antiretroviral treatment (ART) initiation and study the 12-month mortality and loss-to-program of HIV-infected children followed in ART programs in West Africa. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13por Tiendrebeogo, Thierry, Messou, Eugène, Arikawa, Shino, Ekouevi, Didier K, Tanon, Aristophane, Kwaghe, Vivian, Balestre, Eric, Zannou, Marcel Djimon, Poda, Armel, Dabis, François, Jaquet, Antoine, Minga, Albert, Becquet, Renaud“…INTRODUCTION: Sex differences have already been reported in sub‐Saharan Africa for attrition and immunological response after antiretroviral therapy (ART) initiation, but follow‐up was usually limited to the first two to three years after ART initiation. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14por Tassie, Jean-Michel, Malateste, Karen, Pujades-Rodríguez, Mar, Poulet, Elisabeth, Bennett, Diane, Harries, Anthony, Mahy, Mary, Schechter, Mauro, Souteyrand, Yves, Dabis, François“…BACKGROUND: Retention of patients on antiretroviral therapy (ART) over time is a proxy for quality of care and an outcome indicator to monitor ART programs. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15por Vandenhende, Marie-Anne, Bellecave, Pantxika, Recordon-Pinson, Patricia, Reigadas, Sandrine, Bidet, Yannick, Bruyand, Mathias, Bonnet, Fabrice, Lazaro, Estibaliz, Neau, Didier, Fleury, Hervé, Dabis, François, Morlat, Philippe, Masquelier, Bernard“…We aimed to study the prevalence of low-frequency DRMs, detected by Ultra-Deep Sequencing (UDS) before antiretroviral therapy (ART) and at virological failure (VF), in HIV-1 infected patients experiencing VF on first-line ART. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
16por Ekouevi, Didier K, Tchounga, Boris K, Coffie, Patrick A, Tegbe, Joseph, Anderson, Alexandra M, Gottlieb, Geoffrey S, Vitoria, Marco, Dabis, François, Eholie, Serge P“…BACKGROUND: Few data are available on antiretroviral therapy (ART) response among HIV-2 infected patients. We conducted a systematic review on treatment outcomes among HIV-2 infected patients on ART, focusing on the immunological and virological responses in adults. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
17por Arikawa, Shino, Rollins, Nigel, Jourdain, Gonzague, Humphrey, Jean, Kourtis, Athena P, Hoffman, Irving, Essex, Max, Farley, Tim, Coovadia, Hoosen M, Gray, Glenda, Kuhn, Louise, Shapiro, Roger, Leroy, Valériane, Bollinger, Robert C, Onyango-Makumbi, Carolyne, Lockman, Shahin, Marquez, Carina, Doherty, Tanya, Dabis, François, Mandelbrot, Laurent, Le Coeur, Sophie, Rolland, Matthieu, Joly, Pierre, Newell, Marie-Louise, Becquet, Renaud“…Maternal ART and prolonged breastfeeding while on ART may improve survival, although this has not been reliably quantified. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
18por Coffie, Patrick A., Egger, Matthias, Vinikoor, Michael J., Zannou, Marcel, Diero, Lameck, Patassi, Akouda, Kuniholm, Mark H., Seydi, Moussa, Bado, Guillaume, Ocama, Ponsiano, Andersson, Monique I., Messou, Eugène, Minga, Albert, Easterbrook, Philippa, Anastos, Kathryn, Dabis, François, Wandeler, Gilles“…Knowledge of HBV status is important to guide optimal selection of antiretroviral therapy (ART) and monitor/prevent liver-related complications. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
19por Losina, Elena, Touré, Hapsatou, Uhler, Lauren M., Anglaret, Xavier, Paltiel, A. David, Balestre, Eric, Walensky, Rochelle P., Messou, Eugène, Weinstein, Milton C., Dabis, François, Freedberg, Kenneth A.“…Survival losses from LTFU within 1 y of ART initiation ranged from 73.9 to 80.7 mo. The intervention costing US$22/person/year (e.g., eliminating ART co-payment) would be cost-effective with an efficacy of at least 12%. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
20por Gosset, Andréa, Protopopescu, Camelia, Larmarange, Joseph, Orne-Gliemann, Joanna, McGrath, Nuala, Pillay, Deenan, Dabis, François, Iwuji, Collins, Boyer, Sylvie“…OBJECTIVE: To study retention in care (RIC) trajectories and associated factors in patients eligible for antiretroviral therapy (ART) in a universal test-and-treat setting (TasP trial, South Africa, 2012–2016). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto